Iclusig Európska únia - slovenčina - EMA (European Medicines Agency)

iclusig

incyte biosciences distribution b.v. - ponatinib - leukemia, myeloid; leukemia, lymphoid - antineoplastic agents, protein kinase inhibitors - iclusig is indicated in adult patients withchronic phase, accelerated phase, or blast phase chronic myeloid leukaemia (cml) who are resistant to dasatinib or nilotinib; who are intolerant to dasatinib or nilotinib and for whom subsequent treatment with imatinib is not clinically appropriate; or who have the t315i mutationphiladelphia chromosome positive acute lymphoblastic leukaemia (ph+ all) who are resistant to dasatinib; who are intolerant to dasatinib and for whom subsequent treatment with imatinib is not clinically appropriate; or who have the t315i mutation. pozri časti 4. 2 assessment of cardiovascular status prior to start of therapy and 4. 4 situations where an alternative treatment may be considered.

Prokanazol 100 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

prokanazol 100 mg

exeltis slovakia s.r.o., slovensko - itrakonazol - 26 - antimycotica (lokÁlne a celkovÉ)

SPORANOX Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sporanox

johnson & johnson, s.r.o., slovensko - itrakonazol - 26 - antimycotica (lokÁlne a celkovÉ)